Details

MicroRNAs as biomarkers in spinal muscular atrophy
ID Barbo, Maruša (Author), ID Glavač, Damjan (Author), ID Jezernik, Gregor (Author), ID Ravnik-Glavač, Metka (Author)

.pdfPDF - Presentation file, Download (1,03 MB)
MD5: C6F1D11CB9A697465E6D178834329190
URLURL - Source URL, Visit https://www.mdpi.com/2227-9059/12/11/2428 This link opens in a new window

Abstract
Spinal muscular atrophy (SMA) is a severe neurodegenerative disease caused by the loss of the survival motor neuron (SMN) protein, leading to degeneration of anterior motor neurons and resulting in progressive muscle weakness and atrophy. Given that SMA has a single, well-defined genetic cause, gene-targeted therapies have been developed, aiming to increase SMN production in SMA patients. The SMN protein is likely involved in the synthesis of microRNAs (miRNAs), and dysregulated miRNA expression is increasingly associated with the pathophysiology of SMA. Currently, there is a lack of reliable biomarkers to monitor SMA; therefore, the search for novel SMA biomarkers, including miRNAs, is crucial as reliable tools are needed to track disease progression, predict the response to therapy and understand the different clinical outcomes of available treatments. In this review, we compile data on miRNAs associated with SMA pathogenesis and their potential use as biomarkers. Based on current knowledge, the most frequently deregulated miRNAs between SMA patients and controls, as well as pre- and post-treatment in SMA patients, include miR-1-3p, miR-133a-3p, miR-133b, and miR-206. These findings offer promising possibilities for improving patient classification and monitoring disease progression and response to treatment. Additionally, these findings provide insights into the broader molecular mechanisms and networks of SMA that could inform the development of future therapeutic strategies.

Language:English
Keywords:spinal muscular atrophy, SMA, circulating miRNA, biomarkers, molecular networks
Work type:Article
Typology:1.02 - Review Article
Organization:MF - Faculty of Medicine
Publication status:Published
Publication version:Version of Record
Year:2024
Number of pages:16 str.
Numbering:Vol. 12, iss. 11, art. 2428
PID:20.500.12556/RUL-176039 This link opens in a new window
UDC:577
ISSN on article:2227-9059
DOI:10.3390/biomedicines12112428 This link opens in a new window
COBISS.SI-ID:214140931 This link opens in a new window
Publication date in RUL:19.11.2025
Views:92
Downloads:36
Metadata:XML DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:Biomedicines
Shortened title:Biomedicines
Publisher:MDPI
ISSN:2227-9059
COBISS.SI-ID:523006745 This link opens in a new window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Secondary language

Language:Slovenian
Keywords:spinalna mišična atrofija, SMA, cirkulirajoča miRNA, biološki označevalci, molekularne mreže

Projects

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P1-0170
Name:Molekulski mehanizmi uravnavanja celičnih procesov v povezavi z nekaterimi boleznimi pri človeku

Funder:ARIS - Slovenian Research and Innovation Agency
Funding programme:Young researchers

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back